PACT
PACT Pharma, Inc.
Mark For: PACT® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88686146 |
| Registration Number | 6494047 |
| Mark Literal Elements | PACT |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED 2020-02-20 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Cara R. Baer |
| Attorney Docket Number | 50180.202084 |
Timeline
| 2019-11-09 | Application Filed |
| 2019-11-16 | Location: NEW APPLICATION PROCESSING |
| 2019-11-16 | Status: Live/Pending |
| 2019-11-16 | Transaction Date |
| 2020-02-20 | Location: TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED |
| 2020-02-20 | Status: A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additi |
| 2021-09-21 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  PACT Pharma, Inc. |
| Address | 2 Corporate Drive South San Francisco, CALIFORNIA UNITED STATES 94080 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | JPEG | 2019-11-09 |
 TEAS RF New Application | MULTI | 2019-11-09 |
| Offc Action Outgoing | MULTI | 2020-02-20 |
| XSearch Search Summary | XML | 2020-02-20 |
| XSearch Search Summary | XML | 2020-02-20 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for the treatment of genetic diseases, immunological diseases and cancer; personalized cell therapies for medical use; biological preparations for medical purposes, namely, in the field of personalized cell therapies; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; pharmaceuticals, namely, immunotherapies; oncological preparations, namely, pharmaceutical products for the detection and treatment of cancer; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the treatment of cancer and oncological conditions
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances for the treatment of genetic diseases, immunological diseases and cancer; personalized cell therapies for medical use; biological preparations for medical purposes, namely, in the field of personalized cell therapies; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; pharmaceuticals, namely, immunotherapies; oncological preparations, namely, pharmaceutical products for the detection and treatment of cancer; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the treatment of cancer and oncological conditions |
| GS0051 | Pharmaceutical preparations and substances for the treatment of genetic diseases, immunological diseases and cancer; personalized cell therapies for medical use for the treatment of cancer; biological preparations for medical purposes, namely, in the field of personalized cell therapies for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; pharmaceuticals, namely, immunotherapies for the treatment of cancer; oncological preparations, namely, pharmaceutical products for the detection and treatment of cancer; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the treatment of cancer and oncological conditions; none of the foregoing for use in connection with patient self-management, pain management or substance misuse |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-02-20 | 6325 |
| NON-FINAL ACTION WRITTEN | 2020-02-20 | 90288 |
| NON-FINAL ACTION E-MAILED | 2020-02-20 | 6325 |
| ASSIGNED TO EXAMINER | 2020-02-13 | 90288 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-11-16 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-11-13 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 